AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2024

May 21, 2024

30198_dirs_2024-05-21_42cc985c-9999-4652-a5ca-383aadd9ac43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2024-05-18

Reporting Person: AUGUSTINOS NICHOLAS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-18	Common Stock	G	3043	$0.0	Disposed	0	Direct
2024-05-18	Common Stock	G	3043	$0.0	Acquired	37083	Indirect

Footnotes

F1: Shares were transferred from direct ownership to ownership under the Kirschner/Augustinos Revocable Trust, upon vesting of previously awarded restricted stock units.

F2: Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.